Pioneering a Transdisciplinary Urban Surveillance System for Human Papilloma Virus with Vulnerable Communities
Dauer: 24 Monate, Fördersumme: € 699.405
Second generation human papillomavirus (HPV) vaccine for broad-spectrum protection against HPV-induced skin and mucosal neoplasia
Dauer: 60 Monate, Fördersumme: € 800.000